secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ensysce Biosciences, Inc. (ENSC)
CIK:        0001716947
Form:       8-K
Filed at:   2023-05-15T23:59:59+00:00
Accession:  0001493152-23-017038
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ensysce closes $7M public offering of common stock and warrants
---------------------------------------------------------------

- Offered 1,800,876 shares (or pre-funded warrants) plus Series A-1/A-2 warrants at $3.887 per unit.
- Gross proceeds ~$7M; net proceeds for clinical development and working capital.
- H.C. Wainwright acted as exclusive placement agent for the offering.
- Amended 210,085 existing warrants from $16.80-$187.20 to $3.637 per share at $0.125 per amended warrant.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716947/000149315223017038/0001493152-23-017038-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716947/000149315223017038/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-017038

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer